× Development of automated synthesis procedures for radiopharmaceuticals with high molar activity (Am) and quality according to GMP regulations
- Small molecules
- Peptides
- Affibodies (Fab)
× Optimising 18F-radiofluorination methods (electrophilic, transition metal mediated and nucleophilic) for simplicity and high Am (Fig. 1)

× Optimising target performance, 11C-labelling agent pathways and synthesis methods for simplicity, high yields and Am (Fig. 2)

× Radiometal labelling of novel chelating agents, their in vivo characterisation and utilisation in the labelling of bioactive macromolecules for PET imaging